Page last updated: 2024-10-23

bepridil and Glial Cell Tumors

bepridil has been researched along with Glial Cell Tumors in 2 studies

Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tortiglione, A2
Pignataro, G1
Minale, M1
Secondo, A2
Scorziello, A1
Di Renzo, GF1
Amoroso, S2
Caliendo, G1
Santagada, V1
Annunziato, L2
Catalano, A1
Montagnani, S1
Di Renzo, G1

Other Studies

2 other studies available for bepridil and Glial Cell Tumors

ArticleYear
Na+/Ca2+ exchanger in Na+ efflux-Ca2+ influx mode of operation exerts a neuroprotective role in cellular models of in vitro anoxia and in vivo cerebral ischemia.
    Annals of the New York Academy of Sciences, 2002, Volume: 976

    Topics: Adenosine Triphosphate; Amino Acid Sequence; Bepridil; Biological Transport; Brain Ischemia; Calcium

2002
Sodium nitroprusside prevents chemical hypoxia-induced cell death through iron ions stimulating the activity of the Na+-Ca2+ exchanger in C6 glioma cells.
    Journal of neurochemistry, 2000, Volume: 74, Issue:4

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Amiloride; Animals; Bepridil; Calcium; Calcium Channel Block

2000